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Abstract
Background: Hashimoto’s encephalopathy often presents with neuropsychiatric manifestations including seizures and movement disorders.
Case Report: We describe a patient who presented with bilateral hand tremor and mild cognitive defects that fulfilled the criteria for a diagnosis of Hashimoto’s
encephalopathy. There was a rapid response to glucocorticoid therapy with relapse following treatment withdrawal.
Discussion: Recently published clinical criteria for the diagnosis of Hashimoto’s encephalopathy include seizures, myoclonus, hallucinations, or stroke-like
episodes but do not include tremor. Our case had mild cognitive dysfunction and a coarse tremor as the predominant clinical features, which probably represent
mild disease.
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Introduction
Autoimmune encephalitis resulting from many recently discovered
antibodies can induce an array of rare illnesses, many of which can
cause movement disorders. One such illness, Hashimoto’s encephalo-
pathy (HE, also called steroid-responsive encephalopathy associated
with autoimmune thyroiditis [SREAT]) is increasingly recognized as a
cause of neuropsychiatric morbidity. Recently proposed consensus
criteria for HE diagnosis are a major step forward in helping clinicians
identify cases of autoimmune encephalitis caused by antibodies to
neuronal surface antigens and synaptic proteins and promptly initiate
treatment while awaiting research laboratory confirmation.1 Coarse
tremors and myoclonus are often seen in this illness.2–5 Higher titers of
serum thyroperoxidase antibodies are also correlated with more
favorable outcomes.6 The illness is characterized by its responsiveness
to steroid treatment. We report a case illustrating prominent coarse
hand tremors with cognitive impairment but only moderate thyroid
antibody elevation. We discuss challenges in the diagnosis and
treatment due to the evolving status of this disorder.
Case Report
A 34-year-old previously healthy female developed progressively
worsening, predominantly postural bilateral hand tremor over 3
months (Video 1A). Difficulty concentrating, memory lapses, slowed
mentation, apathy, myalgia, and weight loss of 7 kg developed over the
3-month period causing frequent absenteeism from work. A history of
catamenial exacerbations of symptoms was negative. The family
history was unremarkable.
Her Mini Mental Status Examination (MMSE) score was 30, and
the patient declined to see a neuropsychologist or psychiatrist for
further cognitive testing. There was a prominent, asymmetric,
rhythmic, involuntary tremor of both hands only; it predominantly
involved the fingers and was worse in the right hand. It was minimally
present at rest (resting tremor) and during activities (kinetic tremor)
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and was most prominent on outstretching the hands (postural tremor)
as shown in Video 1A. It was also present on the finger to nose test
(intention tremor). The tremor had high frequency and moderate
amplitude (Video 1A). There was neither entrainment nor change on
distraction to support a diagnosis of psychogenic tremor. Features of
parkinsonism or dystonia were not present. The rest of the physical
exam was normal apart from the presence of mild, diffuse thyroid
enlargement.
Blood investigations revealed a normal full blood count, liver
function, renal function, collagen vascular screen, and serum copper
and serum ceruloplasmin levels. The erythrocyte sedimentation rate
was 25 mm/hour. Serum thyroxine, tri-iodothyronine, and thyroid-
stimulating hormone were repeatedly within normal ranges. Ultra-
sonography revealed the presence of mild diffuse thyroid enlargement
with solid and cystic components, and fine-needle biopsy revealed
characteristics consistent with thyroiditis. Magnetic resonance imaging
(MRI) of the brain including T2 fluid-attenuated inversion recovery
sequences and diffusion studies, magnetic resonance angiography of
the brain, MRI of the spinal cord, and electroencephalogram were
normal. Computed axial tomography of the chest, abdomen, and
pelvis showed no evidence of malignancy.
The patient’s antithyroid antibodies were only moderately elevated
(Table 1). Antibodies to glutamic acid decarboxylase, N-methyl-D-
aspartate receptor, and voltage-gated calcium and potassium channels
were also all normal (Table 1). Serum autoantibody measurement
against the N-terminal of a-enolase and neurophysiologic tremor
studies were unavailable. Consent for lumbar puncture was not
obtained.
Probable HE was diagnosed, and prednisolone at a dosage of 10 mg
orally three times daily was started. After 3 months of treatment, the
patient’s tremors had diminished significantly and her subjective
cognitive dysfunction was almost completely resolved, but the
prednisolone dosage was gradually reduced to 5 mg daily because of
weight gain. Unfortunately, there was relapse of tremor (Video 1B) and
subjective cognitive symptoms, but re-introduction of prednisolone 60
mg daily led to tremor disappearance within 48 h (Video 1C).
Cognitive symptoms again improved over the next few weeks. As a
steroid-sparing measure, azathioprine 50 mg orally daily was started
with low-dose prednisolone; this regimen controlled the patient’s
symptoms and allowed her to return to work. After 8 weeks, her liver
enzymes were elevated, and azathioprine had to be withdrawn. Liver
enzyme levels subsequently returned to normal in 6 weeks. Despite
this, after 8 months of follow-up the patient remains minimally
symptomatic, fully functional, and has resumed a normal lifestyle on
oral prednisolone 5 mg daily.
Discussion
Recent expert consensus criteria on autoimmune encephalitis
suggest that a diagnosis of HE can be made when all six of the
following criteria have been met: 1) encephalopathy with seizures,
myoclonus, hallucinations, or stroke-like episodes; 2) subclinical or
mild overt thyroid disease (usually hypothyroidism); 3) brain MRI
normal or with nonspecific abnormalities; 4) presence of serum thyroid
(thyroid peroxidase, thyroglobulin) antibodies; 5) absence of well-
characterized neuronal antibodies in serum and cerebrospinal fluid
(CSF); and 6) reasonable exclusion of alternative causes.1 However,
it was noted that there was no disease-specific cut-off value for these
antibodies; antithyroid antibodies are detected in 13% of healthy
individuals.1,7
This case fulfils most of the above criteria (apart from CSF analysis)
and highlights bilateral coarse hand tremor as a feature at presenta-
tion, which was previously described.4 Cognitive dysfunction in this
case was subtle and not readily objectively detected at the bedside
(perfect MMSE score of 30). The mild symptoms, moderate elevation
Video 1. Segment 1A. Subject at presentation. Hands held outstretched
showing a postural hand tremor more prominent in the right hand.
Segment 1B. Subject after relapse. Postural hand tremor relapse following
steroid withdrawal. Segment 1C. Subject after steroid re-introduction.
Significant tremor reduction on steroid treatment.
Table 1. Serum Antibody Panel
Antibody Level Reference
Range





Antithyroperoxidase 32 0-35 IU/mL
Fixed NMDAR antibody Negative Negative
Anti-VGCC antibody Negative 0–45 pmol/L
Anti-VGKC antibody 6 0–69 pmol/L
Anti-GAD antibody Negative Negative
Abbreviations: GAD, Glutamic Acid Decarboxylase; NMDAR,
N-methyl-D-aspartate Receptor; VGCC, Voltage-gated Calcium
Channel; VGKC, Voltage-gated Potassium Channel.
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of antithyroid antibodies, and absence of neuroimaging and electro-
encephalographic abnormalities suggest that our patient probably has
a mild form of the disease. The observation of catamenial worsening of
tremor and myoclonus in HE has also been previously noted, and both
have been replicated by intravenous administration of thyrotropin-
releasing hormone.5 Catamenial symptom exacerbation was not noted
in this case.
Autoimmune encephalitis has been associated with various anti-
bodies to neural and synaptic proteins, and in our case assays of were
negative apart from antithyroid antibodies, thus ruling out other
known possible causes for the patient’s symptoms (Table 1).
A limitation of this study was the unavailability of neurophysiologic
studies of this tremor as previously summarized by Hess and Pullman.8
Serial neuropsychological testing could have been used to assess subtle
cognitive dysfunction in this case,9,10 but the patient declined to see a
psychiatrist or psychologist.
Video demonstration of movement disorders in HE/SREAT is
uncommon, and the purpose of this report is to draw attention to this
entity in patients presenting with hand tremor and neuropsychiatric
symptoms. New-onset hand tremor is a common clinical presentation
to neurologists, and HE/STREA T should be considered in the
differential diagnosis.11 It is becoming increasingly clear that patients
with autoimmune encephalitis fare better when treated earlier with
glucocorticoid and immunosuppressive, and this may also hold true for
HE/SREAT.1
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